Results 131 to 140 of about 238,159 (194)

Platelet‐Rich Plasma for Rhinitis Medicamentosa: A Promising Histopathological Study in an Animal Model

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To investigate whether platelet‐rich plasma (PRP) has an efficacy on histopathologic changes in rhinitis medicamentosa (RM) in a rat model. Study Design Experimental animal study. Setting University animal laboratory. Methods Forty Wistar albino rats were randomly assigned to five groups to assess the effects of various treatments on
Kamil Gokce Tulaci   +7 more
wiley   +1 more source

Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOP

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Food safety practices are widely recommended for pediatric patients with cancer or undergoing hematopoietic stem cell transplantation (HCT) to mitigate foodborne infectious risks. However, specific measures, such as the neutropenic diet (ND) or low‐microbial diet, lack robust evidence and are inconsistently implemented across ...
Davide Leardini   +28 more
wiley   +1 more source

Effects of a Low Versus Moderate–High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo‐HSCT—The ANIMAL Exploratory Randomized Controlled Trial

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives Pediatric cancer patients undergoing allogeneic hematopoietic stem cell transplantation (allo‐HSCT) are severely immunosuppressed leading to a high risk for life‐threatening infections. This trial investigates the effects of exercise during allo‐HSCT on immune cell recovery and patient‐related outcomes (DRKS00019865). Methods Twenty‐
Ronja Beller   +7 more
wiley   +1 more source

Platelet-rich plasma preparation using three devices: Implications for platelet activation and platelet growth factor release [PDF]

open access: yes, 2006
BOX, HAM   +6 more
core  

Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy Forum

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma is a poor prognosis cancer of the sympathetic nervous system that accounts for a disproportionate number of childhood cancer deaths. Many viable biological targets have been identified, and the number of potential combinations is even larger.
Steven G. DuBois   +44 more
wiley   +1 more source

Home - About - Disclaimer - Privacy